NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/iovance-biotherapeutics-inc-class-action-lawsuit. Investors have until July 14, 2 ...

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in UroGen you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/urogen-pharma-ltd-class-action-lawsuit. Investors have until July 28, 2025, to ask the Court ...

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action. Investors have until July 22, 2025, to ask the Court to be appointed to lea ...

NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Reddit, Inc. (NYSE: RDDT) for potential violations of the federal securities laws. If you invested in Reddit, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/reddit-inc-securities-fraud-class-action. Why is Reddit being Investigated? Reddit owns and operates the eponymous social news aggregation, forum, and social med ...

投资研究平台推广 - 平台提供深度研究服务 涵盖REITs mREITs 优先股 BDCs MLPs ETFs及其他收益型投资工具 [1] - 平台获得438份用户评价 其中多数为五星级好评 [1] - 提供免费两周试用期 吸引潜在用户 [1] 免责声明 - 平台强调分析师观点独立 未持有相关公司股票或衍生品头寸 未来72小时无交易计划 [1] - 平台声明分析师未获得除Seeking Alpha外的其他报酬 与提及公司无商业关系 [1] - 平台整体观点可能与个别分析师存在差异 且不构成投资建议 [2] 平台资质说明 - 平台未持有证券交易商 经纪商或美国投资顾问牌照 [2] - 分析师团队包含专业投资者和未持证个人投资者 [2]

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Oracle. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

根据提供的文档内容，没有涉及具体的公司或行业信息，因此无法提取与公司或行业相关的关键要点。文档内容主要包含分析师和平台的免责声明及披露信息，与投资研究分析无关。建议提供包含具体公司或行业数据的新闻内容以便进行专业分析。

With the first half of 2025 nearly over, many investors are taking time to reevaluate their portfolios and take advantage of quality stocks that can be bought at a discount. It certainly requires some confidence to buy shares of a company when they're down, but it's opportunities like these that offer the potential for outsize returns.Two Fool.com contributors, for example, recognize that oil supermajor Chevron (CVX 0.53%) and data center equipment provider Vertiv (VRT -3.08%) are two worthy considerations ...

Esperion Therapeutics, Inc (NASDAQ: ESPR ) has been running a gauntlet of biotech and healthcare conferences over the past several weeks. The stock has actually responded positively. Still, while it is nice to see a timely 64% rebound off the all-time lowDr. Duru has blogged about financial markets since the year 2000. A veteran of the dot-com bubble and bust, the financial crisis, and the coronavirus pandemic, he fully appreciates the value in trading and investing around the extremes of market behavior. I ...